REFERENCES
- Zacks SL, Fried MW, Hepatitis B, C renal failure. Infect Dis Clin North Am 2001; 15: 877–899, [INFOTRIEVE], [CSA]
- Lopez Alcoronho JM, Barril G, Ortiz Movilla N, et al. Prevalence of hepatitis B, hepatitis C, GB virus C/hepatitis G and TT viruses in hemodialysis patients. J Med Virol 2001; 63: 103–107, [CROSSREF], [CSA]
- Huang CC. Hepatitis in patients with end-stage renal disease. J Gastroenterol Hepatol 1997; 12: 236–241, [CSA]
- Saha D, Agarwal SK. Hepatitis and HIV infection during hemodialysis. J Indian Med Assoc 2001; 99: 194–199, [INFOTRIEVE], [CSA]
- Moreira R, Pinho JRR, Fares J, et al. Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies. Can J Microbiol 2003; 49: 503–507, [INFOTRIEVE], [CROSSREF], [CSA]
- Oesterreicher C, Hammer J, Koch U, et al. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int 1995; 48: 1967–1971, [INFOTRIEVE], [CSA]
- Fabrizi F, Poordad F, Martin P. Hepatitis C infection and the patients with end-stage renal disease. Hepatology 2002; 36: 3–10, [INFOTRIEVE], [CROSSREF], [CSA]
- Stevens CE, Alter HJ, Taylor PE, et al. Hepatitis B vaccine in patients receiving hemodialysis: immunogenicity and efficacy. N Engl J Med 1984; 311: 496–501, [INFOTRIEVE], [CSA]
- Delarocque-Astagneau E, Baffoy N, Thiers V, et al. Outbreak of hepatitis C virus infection in a hemodialysis unit: Potential transmission by hemodialysis machine?. Infect Control Hosp Epidemiol 2002; 23: 328–334, [INFOTRIEVE], [CROSSREF], [CSA]
- Devi KS, Singh NB, Mara J, et al. Seroprevalence of hepatitis B virus and hepatitis C virus among hepatic disorders and injecting drug users in Manipur—a preliminary report. Indian J Med Microbiol 2004; 22: 136–137, [CSA]
- Mutlu B, Meric M, Willke A. Seroprevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors. Mikrobiyol Bul 2004; 38: 445–448, [INFOTRIEVE], [CSA]
- Arankalle VA, Chobe P, Banerjee K. HCV in Pune. J Assoc Physicians India 1992; 40: 562, [INFOTRIEVE], [CSA]
- Baur P, Daniel V, Pomer S, et al. HCV in kidney recipients: Epidemiology and impact on renal transplantation. Ann Hematol 1991; 62: 68–73, [INFOTRIEVE], [CROSSREF], [CSA]
- Bruguera M, Vidal L, Sanchez-Tapias JM, et al. Incidence and features of liver disease in patients on chronic hemodialysis. J Clin Gastroentrol 1990; 20: 5042–5045, [CSA]
- Sato S, Fujiyama S, Tanaka M, et al. Co-infection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 1994; 21: 159–166, [INFOTRIEVE], [CROSSREF], [CSA]
- Pontisso P, Gerotto M, Benvegnu L, et al. Coinfection by hepatitis B virus and hepatitis C virus. Antivir Ther 1998; 3(Suppl. 3)137–142, [INFOTRIEVE], [CSA]
- Sumathy S, Valliammai T, Thyagarajan SP, et al. Prevalence of HCV infection in liver diseases, renal diseases and VBDs in South India. Indian J Med Microbiol 1993; 11: 291–297, [CSA]
- Cabrerizo M, Bartolome J, De Sequera P, et al. Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen negative hemodialysis patients and staff. J Am Soc Nephrol 1997; 8: 1443–1447, [INFOTRIEVE], [CSA]
- Joller-Jemelka HI, Wicki AN, Grob PJ. Detection of HBs antigen in “anti-HBc alone” positive sera. J Hepatol 1994; 21: 269–272, [INFOTRIEVE], [CROSSREF], [CSA]
- Carpenter PA, Huang ML, McDonald GB. Activation of occult hepatitis B from seronegative patient after hematopoietic cell transplant: a cautionary tale. Blood 2002; 99: 4245–4246, [INFOTRIEVE], [CROSSREF], [CSA]
- Besisik F, Karaca C, Akyüz F, et al. Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection. J Hepatol 2003; 38: 506–510, [INFOTRIEVE], [CROSSREF], [CSA]
- Fabrizi F, Martin P, Dixit V, et al. Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients. Am J Nephrol 1999; 19: 383–388, [INFOTRIEVE], [CROSSREF], [CSA]
- Bukh J, Wantzin P, Krogsgaard K, et al. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available anti-body tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group. J Infect Dis 1993; 168: 1343–1348, [INFOTRIEVE], [CSA]
- Kjaha MN, Poduri CD, Habeebullah CM. Modified protocol for HBV DNA isolation and detection. Anal Biochem 2003; 314: 142–143, [CROSSREF], [CSA]
- Kwok S, Higuchi R. Avoiding false positive with PCR. Nature 1989; 339: 237–238, [INFOTRIEVE], [CROSSREF], [CSA]
- Reddy GA, Dakshinamurty KV, Neeelaprasad P, et al. Prevalence of HBV and HCV dual infection in patients on hemodialysis. Indian J Med Microbiol 2005; 23: 41–43, [INFOTRIEVE], [CSA]
- Minuk GY, Sun DF, Greenberg R, et al. Occult hepatitis B virus infection in a North American adult hemodialysis patients population. Hepatology 2004; 40: 1072–1077, [INFOTRIEVE], [CROSSREF], [CSA]
- Mioli VA, Balestra E, Bibiano L, et al. Epidemiology of viral hepatitis in dialysis centers: a national survey. Nephron 1992; 61: 278–283, [INFOTRIEVE], [CSA]
- Almawi WY, Qadi AA, Tamim H, et al. Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia. Transplant Procs 2004; 36: 1824–1826, [CROSSREF], [CSA]
- Qadi AA, Tamin H, Ameen G, et al. Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods. Am J Infect Control 2004; 32: 493–495, [INFOTRIEVE], [CROSSREF], [CSA]
- Chandra M, Kjaha MN, Hussain MM, et al. Prevalence of hepatitis B and hepatitis C viral infections in Indian patients with chronic renal failure. Intervirology 2004; 47: 374–376, [INFOTRIEVE], [CROSSREF], [CSA]
- Covic A, Iancu L, Apetrei C, et al. Hepatitis virus infection in hemodialysis patients from Moldavia. Nephrol Dial Transplant 1999; 14: 40–45, [INFOTRIEVE], [CROSSREF], [CSA]
- Carletti P, Bibino L, Boggi R, et al. HBV infection in hemodialysis patients: monitoring and prevention. Nephron 1992; 61: 269–271, [INFOTRIEVE], [CSA]
- Cendoroglo Neto M, Draibe SA, Silvia AEB, et al. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among hemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant 1995; 10: 240–246, [INFOTRIEVE], [CSA]
- Petrosillo N, Scacia F, Puro V, et al. Hepatitis C transmission in dialysis. Nephron 1993; 63: 115–121, [INFOTRIEVE], [CSA]
- Raccosta G, Merletti MG, Lisi E, et al. Prevalence of hepatitis in our hemodialysis population. Nephron 1992; 61: 300–301, [INFOTRIEVE], [CSA]
- Oguchi H, Miyasaka M, Tokunaga S, et al. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Clin Nephrol 1992; 38: 36–43, [INFOTRIEVE], [CSA]
- Fabrizi F, Raffaele L, Bacchini G, et al. Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic hemodialysis patients: a study second generation assays. Neprol Dial Transplant 1993; 8: 744–747, [CSA]
- Bozdayi G, Rota S, Verdi H, et al. Investigation of the presence of hepatitis C virus infection in hemodialysis patients and determination of HCV genotypes. Mikrobiyol Bul 2002; 36: 291–294, [INFOTRIEVE], [CSA]
- Schroter M, Feucht HH, Schafer P, et al. High percentage of seronegative HCV infections in hemodialysis patients: the need for PCR. Intervirology 1997; 40: 277–278, [INFOTRIEVE], [CSA]
- Triolo G, Squiccimarro G, Baldi M, et al. Antibodies to HCV in kidney transplantation patients. Int Nephrol 1992; 61: 276–277, [CSA]
- Umlauft F, Konig R, Weyres KM, et al. HCV infection among long term hemodialysis patients: Detection of HCV RNA in plasma. Hepatology 1992; 16: 224A, [CROSSREF], [CSA]
- Hruby Z, Sliwinski J, Molin I, et al. High prevalence of antibodies to hepatitis C virus in three hemodialysis centers in south-western Poland. Nephrol Dial Transplant 1993; 8: 740–743, [INFOTRIEVE], [CSA]
- Akpolat T, Arik N, Gunaydin M, et al. Prevalence of anti-HCV among hemodialysis patients in Turkey: a multicentric study. Nephrol Dial Transplant 1995; 10: 479–480, [INFOTRIEVE], [CSA]
- Huraib Al-Rashed R, Aldrees A, Aljerfy M, et al. High prevalence of and risk factors for hepatitis C in hemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Nephrol Dial Transplant 1995; 10: 470–474, [CSA]
- Meyers CM, Seeff LB, Stehman-Bree CO, et al. Hepatitis C and renal disease: An update. Am J Kidney Dis 2003; 42: 631–658, [INFOTRIEVE], [CROSSREF], [CSA]
- Ihara H, Kato T, Ikeda H, et al. Evaluation of HI method as an anti-HBc screening test. Jpn J Transfus Med 1990; 36: 56–61, [CSA]
- Haushofer AC, Hauer R, Brunner H, et al. No evidence of hepatitis B virus activity in patients with anti-HBc antibody positivity with or without anti-hepatitis C virus antibody positivity. J Clin Virol 2004; 29: 221–223, [INFOTRIEVE], [CROSSREF], [CSA]
- Xess A, Kumar M, Minz M, et al. Prevalence of hepatitis B and hepatitis C virus co-infection in chronic liver disease. Indian J Pathol Microbiol 2001; 44: 253–255, [INFOTRIEVE], [CSA]
- Berry N, Chakravati A, Sharma VK, et al. Coinfection with HBV and HIV in HCV infected chronic liver disease. Indian J Med Microbiol 1998; 16: 44, [CSA]
- Kara IH, Yilmaz ME, Sari Y, et al. Seroprevalence and risk factors of HCV in dialysis patients in a university hemodialysis center of East Anatolia, Turkey. Dial Transplant 2001; 30: 748–755, [CSA]
- Fabrizi F, Lunghi G, Andrulli S, et al. Influence of hepatitis C virus (HCV) viremia upon serum aminotransferase activity in chronic dialysis patients. Nephrol Dial Transplant 1997; 12: 1394–1398, [INFOTRIEVE], [CSA]
- Fabrizi F, Mangano S, Alongi G, et al. Influence of hepatitis B virus viremia upon serum aminotransferase activity in dialysis population. Int J Artif Organs 2003; 26: 1048–1055, [INFOTRIEVE], [CSA]
- Fabrizi F, Martin P, Dixit V, et al. Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey. Nephron 1988; 80: 428–433, [CROSSREF], [CSA]
- Lopes EP, Gouveia EC, Albuquerque AC, et al. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia. J Clin Virol 2006; 35: 298–302, [INFOTRIEVE], [CROSSREF], [CSA]